Total Payments
$3,476
2024 Payments
$478.60
Companies
17
Transactions
151
Medicare Patients
21,697
Medicare Billing
$15.5M
Payment Breakdown by Category
Food & Beverage$3,476 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,476 | 151 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $914.21 | 37 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $767.75 | 45 | $0 (2024) |
| Alimera Sciences, Inc. | $404.51 | 29 | $0 (2024) |
| Allergan, Inc. | $339.40 | 15 | $0 (2021) |
| Coherus Biosciences Inc. | $182.92 | 5 | $0 (2023) |
| Celgene Corporation | $123.48 | 1 | $0 (2018) |
| Kala Pharmaceuticals, Inc. | $119.32 | 1 | $0 (2019) |
| ASD SPECIALTY HEALTHCARE, LLC | $104.50 | 1 | $0 (2019) |
| ABBVIE INC. | $98.95 | 5 | $0 (2024) |
| Genentech, Inc. | $92.84 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $478.60 | 23 | Regeneron Healthcare Solutions, Inc. ($142.85) |
| 2023 | $677.88 | 26 | Genentech USA, Inc. ($261.63) |
| 2022 | $321.10 | 18 | Genentech USA, Inc. ($94.17) |
| 2021 | $218.05 | 13 | Genentech USA, Inc. ($87.67) |
| 2020 | $179.45 | 6 | Genentech, Inc. ($92.84) |
| 2019 | $553.08 | 21 | Regeneron Healthcare Solutions, Inc. ($148.27) |
| 2018 | $552.15 | 25 | Alimera Sciences, Inc. ($135.26) |
| 2017 | $495.26 | 19 | Genentech USA, Inc. ($189.23) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: EYE CARE | ||||||
| 10/22/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/24/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/14/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 07/23/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Ophthalmology | ||||||
| 07/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $0.30 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/03/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $40.06 | General |
| Category: Ophthalmology | ||||||
| 06/27/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/11/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/25/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/18/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $36.41 | General |
| Category: Ophthalmology | ||||||
| 04/02/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/26/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Ophthalmology | ||||||
| 03/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/08/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/11/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/14/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/14/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 5,899 | 38,957 | $14.2M | $4.4M |
| 2022 | 22 | 5,555 | 23,076 | $13.4M | $4.1M |
| 2021 | 20 | 5,241 | 17,189 | $12.0M | $3.7M |
| 2020 | 17 | 5,002 | 15,476 | $10.9M | $3.4M |
Total Patients
21,697
Total Services
94,698
Medicare Billing
$15.5M
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 358 | 3,032 | $6.1M | $2.1M | 34.3% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 82 | 21,600 | $1.5M | $624,113 | 41.3% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 133 | 1,741 | $1.4M | $376,436 | 27.0% |
| J3490 | Unclassified drugs | Office | 2023 | 73 | 159 | $656,000 | $320,041 | 48.8% |
| 67028 | Injection of drug into eye | Office | 2023 | 578 | 2,356 | $1.7M | $256,378 | 15.5% |
| 92134 | Imaging of retina | Office | 2023 | 1,324 | 3,684 | $626,280 | $134,516 | 21.5% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 78 | 630 | $504,000 | $116,028 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 757 | 1,137 | $341,100 | $87,487 | 25.6% |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | Office | 2023 | 39 | 480 | $384,000 | $83,915 | 21.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 475 | 928 | $232,000 | $74,870 | 32.3% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 20 | 510 | $153,000 | $61,384 | 40.1% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 21 | 315 | $154,000 | $47,779 | 31.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 281 | 342 | $153,900 | $37,969 | 24.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 153 | 153 | $68,850 | $20,009 | 29.1% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 518 | 681 | $61,290 | $14,605 | 23.8% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 100 | 102 | $30,560 | $12,985 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 82 | 82 | $36,900 | $12,663 | 34.3% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 20 | 23 | $36,000 | $11,114 | 30.9% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 498 | 635 | $53,975 | $8,611 | 16.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 76 | 76 | $22,800 | $7,833 | 34.4% |
| 92250 | Photography of the retina | Office | 2023 | 155 | 167 | $29,225 | $5,621 | 19.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 37 | $12,950 | $4,212 | 32.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 19 | 51 | $25,500 | $2,900 | 11.4% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 24 | 36 | $7,020 | $1,448 | 20.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 378 | 3,330 | $6.7M | $2.4M | 35.6% |
About Dr. David Fastenberg, MD
Dr. David Fastenberg, MD is a Ophthalmology healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336252626.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Fastenberg, MD has received a total of $3,476 in payments from pharmaceutical and medical device companies, with $478.60 received in 2024. These payments were reported across 151 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,476).
As a Medicare-enrolled provider, Fastenberg has provided services to 21,697 Medicare beneficiaries, totaling 94,698 services with total Medicare billing of $15.5M. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Great Neck, NY
- Active Since 08/17/2006
- Last Updated 11/25/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1336252626
Products in Payments
- Lucentis (Biological) $524.11
- EYLEA (Biological) $468.29
- Vabysmo (Drug) $403.37
- OZURDEX (Drug) $339.04
- Cimerli (Biological) $259.39
- EYLEA HD (Biological) $213.68
- Iluvien (Drug) $124.78
- Otezla (Drug) $123.48
- INVELTYS (Drug) $119.32
- RESTASIS (Drug) $99.31
- Tecnis Multifocal Family of 1-piece IOLS (Device) $79.60
- VABYSMO (Drug) $79.57
- EYLEA AFLIBERCEPT INJECTION (Biological) $73.70
- Iluvien (Biological) $68.89
- ILUVIEN (Drug) $53.02
- YUTIQ (Drug) $48.52
- Syfovre (Drug) $37.03
- ACTHAR (Biological) $30.75
- LOTEMAX GEL (Drug) $24.99
- BEOVU (Drug) $13.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Great Neck
Dr. Jonathan Jonisch, Md, MD
Ophthalmology — Payments: $622,818
Ophthalmology $622,818
Philip Ferrone, Md, MD
Ophthalmology — Payments: $144,807
Ophthalmology $144,807
Kenneth Rosenthal, Md, MD
Ophthalmology — Payments: $72,719
Ophthalmology $72,719
Dr. David Rhee, Md, MD
Ophthalmology — Payments: $13,182
Ophthalmology $13,182
George Tung, Md, MD
Ophthalmology — Payments: $7,576
Ophthalmology $7,576
Juan Romero, Md, MD
Ophthalmology — Payments: $6,910
Ophthalmology $6,910